ArticleJournal of cellular and molecular medicine2021

Sparstolonin B exerts beneficial effects on prostate cancer by acting on the reactive oxygen species-mediated PI3K/AKT pathway.

Shaozhuang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.